Compare ALIT & EMBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ALIT | EMBC |
|---|---|---|
| Founded | 2017 | 1924 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 394.4M | 354.1M |
| IPO Year | 2020 | 2021 |
| Metric | ALIT | EMBC |
|---|---|---|
| Price | $12.50 | $6.35 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 5 | 4 |
| Target Price | ★ $16.33 | $4.00 |
| AVG Volume (30 Days) | 716.0K | ★ 800.4K |
| Earning Date | 11-03-2026 | 11-24-2026 |
| Dividend Yield | ★ 6.22% | 0.65% |
| EPS Growth | N/A | ★ 20.90 |
| EPS | N/A | ★ 1.03 |
| Revenue | ★ $2,262,000,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $5.59 |
| P/E Ratio | ★ N/A | $6.00 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.48 | $2.77 |
| 52 Week High | $23.68 | $14.91 |
| Indicator | ALIT | EMBC |
|---|---|---|
| Relative Strength Index (RSI) | 65.85 | 53.84 |
| Support Level | $8.20 | $3.01 |
| Resistance Level | $13.21 | $6.90 |
| Average True Range (ATR) | 1.15 | 0.33 |
| MACD | 0.57 | -0.06 |
| Stochastic Oscillator | 51.28 | 53.12 |
Alight Inc is a technology-enabled services company delivering human capital management solutions to many complex organizations. This includes the implementation and administration of employee benefits (e.g., health, wealth, and leave benefits) solutions, which currently operate under one reportable segment, Employer Solutions. The Employer Solutions segment is driven by the Alight Worklife platform, and includes integrated benefits administration, healthcare navigation, financial well-being, leave of absence management, and retiree healthcare. Geographically, the company generates the majority of its revenue from the United States.
Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.